The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 533 KB) and Technical Notes (PDF, 752 KB) pages.


Download and Print: Download Printer-friendly PDF Download data

Table 32.11

Age-Adjusted SEER Incidencea , by Year and Sex

By Adapted Classification Scheme for Tumors of Adolescents and Young Adultsb

All Races, Ages 35-39

Both Sexes
Site 1975-2011 2002-2011
Count Rate AAPCc Count Rate AAPCc
All Sites Combined 91,805 132.7 0.8* 27,810 138.0 0.9*
1. Leukemias 2,583 3.7 0.2 777 3.9 0.2
2. Lymphomas 7,726 11.2 1.6* 2,250 11.2 -1.4*
3. CNS, intracranial, intraspinal 2,736 4.0 -0.2 758 3.8 -0.2
4. Osseous & chondromatous neoplasms 456 0.7 1.4* 154 0.8 1.4*
5. Soft tissue sarcomas 5,935 8.6 1.1 1,025 5.1 -1.0
6. Germ cell and trophoblastic neoplasms 4,060 5.9 1.7* 1,311 6.5 0.3
7. Melanoma and skin carcinomas 10,003 14.5 1.6* 3,148 15.6 0.4*
8. Carcinomas (excluding skin) 56,654 81.9 0.5 17,877 88.7 1.4*
9. Miscellaneous specified neoplasms, NOS 1,178 1.7 1.1* 391 1.9 1.1*
10. Unspecified malignant neoplasms 474 0.7 -0.2 119 0.6 -0.2
Males
Site 1975-2011 2002-2011
Count Rate AAPCc Count Rate AAPCc
All Sites Combined 34,583 100.3 0.6 9,688 96.2 0.1
1. Leukemias 1,500 4.4 0.1 443 4.4 0.1
2. Lymphomas 5,044 14.6 1.8* 1,373 13.6 -0.7
3. CNS, intracranial, intraspinal 1,604 4.7 -0.1 439 4.4 -0.1
4. Osseous & chondromatous neoplasms 262 0.8 0.8 88 0.9 0.8
5. Soft tissue sarcomas 4,683 13.6 2.6 674 6.7 -1.3
6. Germ cell and trophoblastic neoplasms 3,851 11.2 1.8* 1,245 12.4 0.3
7. Melanoma and skin carcinomas 4,362 12.7 0.7 1,253 12.4 -0.6
8. Carcinomas (excluding skin) 12,614 36.6 0.2 3,977 39.5 1.4*
9. Miscellaneous specified neoplasms, NOS 471 1.4 0.5 153 1.5 0.5
10. Unspecified malignant neoplasms 192 0.6 -0.7 43 0.4 -0.7
Females
Site 1975-2011 2002-2011
Count Rate AAPCc Count Rate AAPCc
All Sites Combined 57,222 164.9 0.7* 18,122 179.7 1.2*
1. Leukemias 1,083 3.1 0.9 334 3.3 2.4*
2. Lymphomas 2,682 7.7 1.4* 877 8.7 1.4*
3. CNS, intracranial, intraspinal 1,132 3.3 -0.3 319 3.2 -0.3
4. Osseous & chondromatous neoplasms 194 0.6 - 66 0.7 -
5. Soft tissue sarcomas 1,252 3.6 -0.6 351 3.5 -0.6
6. Germ cell and trophoblastic neoplasms 209 0.6 -0.1 66 0.7 -0.1
7. Melanoma and skin carcinomas 5,641 16.3 2.1* 1,895 18.8 1.8*
8. Carcinomas (excluding skin) 44,040 126.9 0.6 13,900 137.8 1.4*
9. Miscellaneous specified neoplasms, NOS 707 2.0 1.4* 238 2.4 1.4*
10. Unspecified malignant neoplasms 282 0.8 -0.1 76 0.8 -0.1

Footnotes:

Rates are per 100,000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130).

a Rates are from the SEER 9 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta).

b Adapted from: RD Barr, EJ Holowaty, JM Birch. Classification Scheme for tumors diagnosed in adolescents and young adults. Cancer. 106:7; 1425-1430. (Restricted to malignant tumors and updated based on ICD-O-3 definitions).

c The AAPC is the Average Annual Percent Change and is based on the APCs calculated by Joinpoint over the time range of 1975-2011.

- Statistic could not be calculated. Count and rate based on less than 16 cases for the time interval. AAPC could not be calculated due to insufficient data.

* The AAPC is significantly different from zero (p<.05).

Page Navigation: << Previous Next >>

The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.